Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
InfuSystem Holdings, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $0.0001 Par Value
--------------------------------------------------------------------------------
(Title of Class of Securities)
45685K102
--------------------------------------------------------------------------------
(CUSIP Number)
Lisa Thenell, Chief Compliance Officer
Acuitas Investments, LLC
520 Pike Street, Suite 1221, Seattle, WA 98101, 206-299-2073
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
December 31, 2023
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
|X| Rule 13d-1(b)
|_| Rule 13d-1(c)
|_| Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
--------------------------------------------------------------------------------
CUSIP No. 45685K102 13G Page 2 of 5 Pages
--------------------------------------------------------------------------------
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
Acuitas Investments, LLC
27-3889854
--------------------------------------------------------------------------------
2. Check the Appropriate Box If a Member of a Group
(See Instructions)
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3. SEC Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization
Washington, USA
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
0
-------------------------------------------------------------
6. SHARED VOTING POWER
NUMBER OF
SHARES 1,225,151
BENEFICIALLY -------------------------------------------------------------
OWNED BY EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH 0
-------------------------------------------------------------
8. SHARED DISPOSITIVE POWER
1,225,151
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
1,225,151
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions) |_|
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9)
5.8%
Based on a total of 21,183,526 shares of the Issuer's Common Stock
outstanding as of November 5, 2023, as reported in the Issuer's
Quarterly Report on Form 10-Q for the period ended September 30, 2023.
--------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions)
IA
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
CUSIP No. 45685K102 13G Page 3 of 5 Pages
Item 1.
(a) Name of Issuer:
InfuSystem Holdings, Inc.
(b) Address of Issuer's Principal Executive Offices:
3851 West Hamlin Road, Rochester Hills, MI 48309
Item 2.
(a) Name of Person Filing:
Acuitas Investments, LLC
(b) Address of the Principal Office or, if none, residence:
520 Pike Street, Suite 1221, Seattle, WA 98101
(c) Citizenship:
Washington, USA
(d) Title of Class of Securities:
Common Stock, $0.0001 Par Value
(e) CUSIP Number:
45685K102
Item 3. If this statement is filed pursuant to SS.240.13d-1(b) or 240.13d-2(b)
or (c), check whether the person filing is a:
(a) |_| Broker or dealer registered under section 15 of the Act
(15 U.S.C. 78o).
(b) |_| Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c) |_| Insurance company as defined in section 3(a)(19) of the Act
(15 U.S.C. 78c).
(d) |_| Investment company registered under section 8 of the Investment
Company Act of 1940 (15 U.S.C 80a-8).
(e) |X| An investment adviser in accordance with S.240.13d-1(b)(1)(ii)(E);
(f) |_| An employee benefit plan or endowment fund in accordance with
S.240.13d-1(b)(1)(ii)(F);
(g) |_| A parent holding company or control person in accordance with
S. 240.13d-1(b)(1)(ii)(G);
(h) |_| A savings associations as defined in Section 3(b) of the Federal
Deposit Insurance Act (12 U.S.C. 1813);
(i) |_| A church plan that is excluded from the definition of an investment
company under section 3(c)(14) of the Investment Company Act of
1940 (15 U.S.C. 80a-3);
(j) |_| Group, in accordance with S.240.13d-1(b)(1)(ii)(J).
--------------------------------------------------------------------------------
CUSIP No. 45685K102 13G Page 4 of 5 Pages
Item 4. Ownership
Provide the following information regarding the aggregate number and percentage
of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned: 1,225,151
(b) Percent of class: 5.8%
Based on a total of 21,183,526 shares of the Issuer's Common Stock
outstanding as of November 5, 2023, as reported in the Issuer's
Quarterly Report on Form 10-Q for the period ended September 30, 2023.
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote: 0
(ii) Shared power to vote or to direct the vote: 1,225,151
(iii) Sole power to dispose or to direct the disposition
of: 0
(iiii) Shared power to dispose or to direct the disposition
of: 1,225,151
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof
the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the following |_|.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company or Control Person.
Item 8. Identification and Classification of Members of the Group
Item 9. Notice of Dissolution of Group
Item 10. Certification
(a) The following certification shall be included if the statement is
filed pursuant to S.240.13d-1(b):
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired and are held in
the ordinary course of business and were not acquired and are not held
for the purpose of or with the effect of changing or influencing the
control of the issuer of the securities and were not acquired and are
not held in connection with or as a participant in any transaction
having that purpose or effect.
--------------------------------------------------------------------------------
CUSIP No. 45685K102 13G Page 5 of 5 Pages
(b) The following certification shall be included if the statement is
filed pursuant to S.240.13d-1(c):
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not
held for the purpose of or with the effect of changing or influencing
the control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any transaction
having that purpose or effect.
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
02/02/2024
-------------------------------------------
Date
/s/ Lisa Thenell
-------------------------------------------
Signature
Lisa Thenell, Chief Compliance Officer
-------------------------------------------
Name/Title